The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
Mark Haas(Cedars-Sinai Medical Center), Alexandre Loupy(Délégation Paris 5), Carmen Lefaucheur(Inserm), Candice Roufosse(North West London Pathology), Denis Glotz(Inserm), Daniel Serón(Universitat Autònoma de Barcelona), Brian J. Nankivell(Westmead Hospital), Philip F. Halloran(University of Alberta), Robert B. Colvin(Harvard University), Enver Akalin(Albert Einstein College of Medicine), Nada Alachkar(Johns Hopkins University), Serena M. Bagnasco(Johns Hopkins University), Yassine Bouatou(Délégation Paris 5), Jan U. Becker(University Hospital Cologne), Lynn D. Cornell(Mayo Clinic in Arizona), J.P. Duong Van Huyen(Délégation Paris 5), Ian W. Gibson(University of Manitoba), Edward S. Kraus(Johns Hopkins University), Roslyn B. Mannon(University of Alabama), Maarten Naesens(KU Leuven), Volker Nickeleit(University of North Carolina at Chapel Hill), Peter Nickerson(University of Manitoba), Dorry L. Segev(Johns Hopkins University), Harsharan K. Singh(University of North Carolina at Chapel Hill), Mark D. Stegall(Mayo Clinic in Arizona), Parmjeet Randhawa(University of Pittsburgh), Lorraine C. Racusen(Johns Hopkins University), Kim Solez(University of Alberta), Michael Mengel(University of Alberta)
Cited by 1,025Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis